Ansell reported $937.8M in Sales Revenues for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Ansell ANN:AU $ 937.8M 77.4M
Australian Pharma API:AU $ 1.99B 47.38M
Cochlear COH:AU $ 743.2M 178.3M
CSL CSL:AU $ 5.74B 1.5B
Estia Health EHE:AU $ 322.5M 1.67M
Fisher Paykel Healthcare FPH:NZ 910.2M 217.4M
GUD GUD:AU $ 251.47M 40.57M
Healius Ltd HLS:AU $ 63.95M 30.56M
Japara Healthcare JHC:AU 237.98M 53.71M
Mayne Pharma MYX:AU $ 209.44M 20.59M
Nanosonics Ltd NAN:AU $ 43.15M 8.38M
Next Science Ltd NXS:AU 2.39M 1.33M
Polynovo Ltd PNV:AU 12.8M 817.57K
Ramsay Health Care RHC:AU $ 6.33B 496.72M
Regis Healthcare REG:AU 369.03M 52.64M
Sigma Healthcare Ltd SIG:AU 1.69B 274.38M
Somnomed Ltd SOM:AU 30.82M 6.77M
Sonic Healthcare SHL:AU $ 4.43B 940.98M